Sarcopenia in Chronic Obstructive Pulmonary Disease: A Study of Prevalence and Associated Factors in the Southeast Asian Population

Overview

Journal Chron Respir Dis

Publisher Sage Publications

Date 2017 Dec 1

PMID 29186972

Citations 33

Authors

Panita Limpawattana

Pratchaya Inthasuwan

Siraphong Putraveephong

Watchara Boonsawat

Daris Theerakulpisut

Kittisak Sawanyawisuth

Affiliations

Soon will be listed here.

Abstract

Chronic obstructive pulmonary disease (COPD) has been described as a systemic disease. Sarcopenia is one of the systemic effects that is related to several adverse outcomes. The objectives of this study were to estimate the prevalence of sarcopenia and to determine the factors associated with sarcopenia in COPD patients in Southeast Asia. This was a cross-sectional study of COPD patients who attended a COPD clinic from May 2015 to December 2016. Baseline characteristics were collected and dual-energy X-ray absorptiometry was used to measure skeletal muscle mass. Handgrip strength was used to assess muscle strength, and as a measurement of physical performance, the 6-min walk distance was used. One hundred and twenty-one participants were recruited. Most of them were men (92.6%). Prevalence of sarcopenia was 24% (29 cases). Independent factors associated with sarcopenia were age ≥ 75 years (adjusted odds ratio (AOR) 13.3, severity of COPD (AOR 19.2 and 13.4 for moderate and severe COPD), Modified Medical Research Council (MMRC) scale (AOD 1.9), and obesity (AOR 0.04). Sarcopenia affects about one-quarter of COPD patients. Age, severity of COPD, MMRC scale, and BMI status were the factors associated with sarcopenia.

Citing Articles

Exploring the relationship between sarcopenia and 11 respiratory diseases: a comprehensive mendelian randomization analysis.

Su Y, Zhang Y, Zhang D, Xu J Aging Clin Exp Res. 2024; 36(1):205.

PMID: 39395132 PMC: 11470909. DOI: 10.1007/s40520-024-02855-y.

Association of Nutritional Intake with Physical Activity and Handgrip Strength in Individuals with Airflow Limitation.

Heo I, Kim T, Jeong J, Heo M, Ju S, Yoo J Tuberc Respir Dis (Seoul). 2024; 88(1):120-129.

PMID: 39391953 PMC: 11704729. DOI: 10.4046/trd.2024.0017.

Risk Factors of Sarcopenia in COPD Patients: A Meta-Analysis.

Zhou J, Liu Y, Yang F, Jing M, Zhong X, Wang Y Int J Chron Obstruct Pulmon Dis. 2024; 19:1613-1622.

PMID: 39011123 PMC: 11246983. DOI: 10.2147/COPD.S456451.

Perspectives of family caregivers and nurses on hospital discharge transitional care for Muslim older adults living with COPD: a qualitative study.

Jehloh L, Songwathana P, Kitrungrote L, Bourbonnais A BMC Nurs. 2024; 23(1):273.

PMID: 38659051 PMC: 11044287. DOI: 10.1186/s12912-024-01943-8.

Chronic obstructive pulmonary disease as a risk factor for sarcopenia: A systematic review and meta-analysis.

Yu Z, He J, Chen Y, Zhou Z, Wang L PLoS One. 2024; 19(4):e0300730.

PMID: 38635756 PMC: 11025915. DOI: 10.1371/journal.pone.0300730.

References

Visser M, Schaap L . Consequences of sarcopenia. Clin Geriatr Med. 2011; 27(3):387-99. DOI: 10.1016/j.cger.2011.03.006. View

Kim T, Park M, Yang S, Yoo H, Kang H, Song W . Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS). Diabetes Care. 2010; 33(7):1497-9. PMC: 2890348. DOI: 10.2337/dc09-2310. View

Kim T, Choi K . Sarcopenia: definition, epidemiology, and pathophysiology. J Bone Metab. 2014; 20(1):1-10. PMC: 3780834. DOI: 10.11005/jbm.2013.20.1.1. View

DePew Z, Karpman C, Novotny P, Benzo R . Correlations between gait speed, 6-minute walk distance, physical activity, and self-efficacy in patients with severe chronic lung disease. Respir Care. 2013; 58(12):2113-9. PMC: 4005406. DOI: 10.4187/respcare.02471. View

Baumgartner R, Waters D, Gallagher D, Morley J, Garry P . Predictors of skeletal muscle mass in elderly men and women. Mech Ageing Dev. 1999; 107(2):123-36. DOI: 10.1016/s0047-6374(98)00130-4. View

Lerario M, Sachs A, Lazaretti-Castro M, Saraiva L, Jardim J . Body composition in patients with chronic obstructive pulmonary disease: which method to use in clinical practice?. Br J Nutr. 2006; 96(1):86-92. DOI: 10.1079/bjn20061798. View

Ischaki E, Papatheodorou G, Gaki E, Papa I, Koulouris N, Loukides S . Body mass and fat-free mass indices in COPD: relation with variables expressing disease severity. Chest. 2007; 132(1):164-9. DOI: 10.1378/chest.06-2789. View

. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166(1):111-7. DOI: 10.1164/ajrccm.166.1.at1102. View

Lee D, Choi E . Sarcopenia as an Independent Risk Factor for Decreased BMD in COPD Patients: Korean National Health and Nutrition Examination Surveys IV and V (2008-2011). PLoS One. 2016; 11(10):e0164303. PMC: 5066961. DOI: 10.1371/journal.pone.0164303. View

10.

Angulo J, El Assar M, Rodriguez-Manas L . Frailty and sarcopenia as the basis for the phenotypic manifestation of chronic diseases in older adults. Mol Aspects Med. 2016; 50:1-32. DOI: 10.1016/j.mam.2016.06.001. View

11.

Cruz-Jentoft A, Baeyens J, Bauer J, Boirie Y, Cederholm T, Landi F . Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010; 39(4):412-23. PMC: 2886201. DOI: 10.1093/ageing/afq034. View

12.

Beaudart C, Rizzoli R, Bruyere O, Reginster J, Biver E . Sarcopenia: burden and challenges for public health. Arch Public Health. 2015; 72(1):45. PMC: 4373245. DOI: 10.1186/2049-3258-72-45. View

13.

Rizzoli R, Reginster J, Arnal J, Bautmans I, Beaudart C, Bischoff-Ferrari H . Quality of life in sarcopenia and frailty. Calcif Tissue Int. 2013; 93(2):101-20. PMC: 3747610. DOI: 10.1007/s00223-013-9758-y. View

14.

Limpawattana P, Putraveephong S, Inthasuwan P, Boonsawat W, Theerakulpisut D, Chindaprasirt J . Frailty syndrome in ambulatory patients with COPD. Int J Chron Obstruct Pulmon Dis. 2017; 12:1193-1198. PMC: 5402886. DOI: 10.2147/COPD.S134233. View

15.

Cesari M, Pedone C, Chiurco D, Cortese L, Conte M, Scarlata S . Physical performance, sarcopenia and respiratory function in older patients with chronic obstructive pulmonary disease. Age Ageing. 2011; 41(2):237-41. DOI: 10.1093/ageing/afr167. View

16.

Steiner M, BARTON R, Singh S, Morgan M . Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. Eur Respir J. 2002; 19(4):626-31. DOI: 10.1183/09031936.02.00279602. View

17.

Stenton C . The MRC breathlessness scale. Occup Med (Lond). 2008; 58(3):226-7. DOI: 10.1093/occmed/kqm162. View

18.

Wagner P . Possible mechanisms underlying the development of cachexia in COPD. Eur Respir J. 2008; 31(3):492-501. DOI: 10.1183/09031936.00074807. View

19.

Chen L, Liu L, Woo J, Assantachai P, Auyeung T, Bahyah K . Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014; 15(2):95-101. DOI: 10.1016/j.jamda.2013.11.025. View

20.

Hanania N, Sharma G, Sharafkhaneh A . COPD in the elderly patient. Semin Respir Crit Care Med. 2010; 31(5):596-606. DOI: 10.1055/s-0030-1265900. View